Meglitinides

B855 Pill - red round

Pill with imprint B855 is Red, Round and has been identified as Repaglinide 2 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Repaglinide is used in the treatment of Diabetes, Type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-B855-2 mg-Red-Round

Repaglinide
Generic Name: repaglinide (oral) [ re-pag-li-nide ]
Imprint: B855
Strength: 2 mg
Color: Red
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Meglitinides
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 51991-0855 (Discontinued)
Inactive Ingredients: Microcrystalline cellulose, Polacrilin potassium, Povidone k30, Magnesium stearate, Poloxamer 407, Calcium phosphate dibasic anhydrous, Ferric oxide red,
Latest News
Related Drugs